"Comprehensive Cancer Centers, an affiliate of The US Oncology Network, is an award-winning multispecialty practice comprising medical oncology, hematology, radiation oncology, breast surgery, pulmonary medicine, cancer genetic counseling and clinical research."

During the past decade, Comprehensive Cancer Centers of Nevada-Horizon Ridge conducted 100 clinical trials. In the 10-year time frame, 100 clinical trials started and 21 clinical trials were completed, i.e. on average, 21% percent of trials that started reached the finish line to date. In the past 5 years, 40 clinical trials started and 21 clinical trials were completed. i.e. 52.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Comprehensive Cancer Centers of Nevada-Horizon Ridge" #1 sponsor was "National Cancer Institute (NCI)" with 50 trials, followed by "Alliance for Clinical Trials in Oncology" with 20 trials sponsored, "SWOG Cancer Research Network" with 19 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 12 trials sponsored and "Children's Oncology Group" with 12 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Comprehensive Cancer Centers of Nevada-Horizon Ridge" #1 collaborator was "National Cancer Institute (NCI)" with 56 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Comprehensive Cancer Centers of Nevada-Horizon Ridge" are "Invasive Breast Carcinoma" (6 trials), "Stage IV Lung Cancer AJCC v8" (6 trials), "Recurrent Lung Non-Small Cell Carcinoma" (5 trials), "Recurrent Ovarian Carcinoma" (4 trials) and "Stage IV Renal Cell Cancer AJCC v8" (4 trials). Many other conditions were trialed in "Comprehensive Cancer Centers of Nevada-Horizon Ridge" in a lesser frequency.

Most popular intervention types in "Comprehensive Cancer Centers of Nevada-Horizon Ridge" are "Drug" (85 trials), "Other" (61 trials), "Biological" (47 trials), "Procedure" (36 trials) and "Radiation" (10 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (27 trials), "Computed Tomography" (23 trials), "Biospecimen Collection" (22 trials), "Laboratory Biomarker Analysis" (20 trials) and "Nivolumab" (19 trials). Other intervention names were less common.

The vast majority of trials in "Comprehensive Cancer Centers of Nevada-Horizon Ridge" are 96 trials for "All" genders, 9 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Comprehensive Cancer Centers of Nevada-Horizon Ridge". undefined are not yet recruiting, 40 are recruiting, 53 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Comprehensive Cancer Centers of Nevada-Horizon Ridge, 4 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Comprehensive Cancer Centers of Nevada-Horizon Ridge, 2 "Phase 1" clinical trials were conducted, 56 "Phase 2" clinical trials and 50 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".